Marks and McCrary receive funding from Gilead to expand blood-borne virus (HIV, HBV, HCV) screenings and linkage to care (Links to an external site)

Laura Marks, MD, Ph.D., and Madeline McCrary, MD, assistant professors of medicine at Washington University School of Medicine in St. Louis, have received a FOCUS grant from Gilead Sciences, Inc. to improve the rates of HIV, HCV, and HBV screenings and linkage to care. In the U.S., the FOCUS Program is a public health initiative that […]

WashU, Eisai form drug discovery collaboration (Links to an external site)

Washington University School of Medicine in St. Louis and the pharmaceutical company Eisai Co. Ltd., headquartered in Japan, have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions.